{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:07:00Z","timestamp":1791313620909,"version":"4.3.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:00:00Z","timestamp":1536537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1038\/s41375-018-0245-3","type":"journal-article","created":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T12:36:14Z","timestamp":1536582974000},"page":"2527-2535","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7444-7652","authenticated-orcid":false,"given":"Morten","family":"Tulstrup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Grosjean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stine Nygaard","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrine","family":"Grell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin Ole","family":"Wolthers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peder Skov","family":"Wegener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olafur Gisli","family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bendik","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arja","family":"Harila-Saari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Abrahamsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goda","family":"Vaitkeviciene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaie","family":"Pruunsild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Toft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Huleg\u00e5rdh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigurd","family":"Liest\u00f8l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laimonas","family":"Griskevicius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Punab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene D.","family":"Dalgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramneek","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Nersting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjeld","family":"Schmiegelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,10]]},"reference":[{"key":"245_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/BF01119794","volume":"9","author":"GB Elion","year":"1989","unstructured":"Elion GB. The purine path to chemotherapy. Biosci Rep. 1989;9:509\u201329.","journal-title":"Biosci Rep"},{"key":"245_CR2","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00228-012-1251-4","volume":"68","author":"TA Beaumais De","year":"2012","unstructured":"De Beaumais TA, Jacqz-Aigrain E. Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia. Eur J Clin Pharmacol. 2012;68:1233\u201342.","journal-title":"Eur J Clin Pharmacol"},{"key":"245_CR3","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1182\/blood.V92.10.3569","volume":"92","author":"FM Balis","year":"1998","unstructured":"Balis FM, Holcenberg JS, Poplack DG, Ge J, Sather HN, Murphy RF, et al. Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a Joint Children\u2019s Cancer Group and Pediatric Oncology Branch Study. Blood. 1998;92:3569\u201377.","journal-title":"Blood"},{"key":"245_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/bmb\/ldl020","volume":"79\u201380","author":"P Karran","year":"2006","unstructured":"Karran P. Thiopurines, DNA damage, DNA repair and therapy-related cancer. Br Med Bull. 2006;79\u201380:153\u201370.","journal-title":"Br Med Bull"},{"key":"245_CR5","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/MPH.0000000000000206","volume":"36","author":"K Schmiegelow","year":"2014","unstructured":"Schmiegelow K, Nielsen SN, Frandsen TL, Nersting J. Mercaptopurine\/methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction. J Pediatr Hematol Oncol. 2014;36:503\u201317.","journal-title":"J Pediatr Hematol Oncol"},{"key":"245_CR6","first-page":"176362","volume":"2017","author":"NA Evensen","year":"2018","unstructured":"Evensen NA, Madhusoodhan PP, Meyer J, Saliba J, Chowdhury A, Araten DJ, et al. MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia. Haematologica. 2018;2017:176362.","journal-title":"Haematologica"},{"key":"245_CR7","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00280-016-3151-2","volume":"78","author":"SN Nielsen","year":"2016","unstructured":"Nielsen SN, Grell K, Nersting J, Frandsen TL, Hjalgrim LL, Schmiegelow K. Measures of 6-mercaptopurine and methotrexate maintenance therapy intensity in childhood acute lymphoblastic leukemia. Cancer Chemother Pharmacol . 2016;78:983\u201394.","journal-title":"Cancer Chemother Pharmacol"},{"key":"245_CR8","first-page":"1","volume":"2045","author":"SN Nielsen","year":"2017","unstructured":"Nielsen SN, Grell K, Nersting J, Abrahamsson J, Lund B, Kanerva J, et al. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial. Lancet Oncol. 2017;2045:1\u201310.","journal-title":"Lancet Oncol"},{"key":"245_CR9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature02626","volume":"429","author":"WE Evans","year":"2004","unstructured":"Evans WE, Relling MV. Moving towards individualized medicine with pharmacogenomics. Nature. 2004;429:464\u20138.","journal-title":"Nature"},{"key":"245_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/clpt.2010.320","volume":"89","author":"MV Relling","year":"2011","unstructured":"Relling MV, Gardner EE, Sandborn WJ, Schmiegelow K, Pui C-H, Yee SW, et al. Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin Pharmacol Ther. 2011;89:387\u201391.","journal-title":"Clin Pharmacol Ther"},{"key":"245_CR11","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/ejh.12097","volume":"90","author":"N Toft","year":"2013","unstructured":"Toft N, Birgens H, Abrahamsson J, Bernell P, Gri\u0161kevi\u010dius L, Hallb\u00f6\u00f6k H, et al. Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol. Eur J Haematol. 2013;90:404\u201312.","journal-title":"Eur J Haematol"},{"key":"245_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejca.2013.09.027","volume":"50","author":"TL Frandsen","year":"2014","unstructured":"Frandsen TL, Heyman M, Abrahamsson J, Vettenranta K, \u00c5sberg A, Vaitkeviciene G, et al. Complying with the European Clinical Trials directive while surviving the administrative pressure - an alternative approach to toxicity registration in a cancer trial. Eur J Cancer. 2014;50:251\u20139.","journal-title":"Eur J Cancer"},{"key":"245_CR13","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/leu.2017.265","volume":"32","author":"N Toft","year":"2018","unstructured":"Toft N, Birgens H, Abrahamsson J, Gri\u0161kevi\u010dius L, Hallb\u00f6\u00f6k H, Heyman M. et al. Results of NOPHO ALL2008 treatment for patients aged 1\u201345 years with acute lymphoblastic leukemia. Leukemia. 2018;32:606\u201315.","journal-title":"Leukemia"},{"key":"245_CR14","first-page":"1","volume":"93","author":"M Tulstrup","year":"2017","unstructured":"Tulstrup M, Frandsen TL, Abrahamsson J, Lund B, Vettenranta K, Jonsson OG, et al. Individualized 6-mercaptopurine increments in consolidation treatment of childhood acute lymphoblastic leukemia: a NOPHO randomized controlled trial. Eur J Haematol. 2017;93:1\u20138.","journal-title":"Eur J Haematol"},{"key":"245_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jchromb.2011.11.032","volume":"881\u20132","author":"JH Jacobsen","year":"2012","unstructured":"Jacobsen JH, Schmiegelow K, Nersting J. Liquid chromatography-tandem mass spectrometry quantification of 6-thioguanine in DNA using endogenous guanine as internal standard. J Chromatogr B Anal Technol Biomed Life Sci. 2012;881\u20132:115\u20138.","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"245_CR16","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1373\/49.2.260","volume":"49","author":"M Shipkova","year":"2003","unstructured":"Shipkova M, Armstrong VW, Wieland E, Oellerich M. Differences in nucleotide hydrolysis contribute to the differences between erythrocyte 6-thioguanine nucleotide concentrations determined by two widely used methods. Clin Chem. 2003;49:260\u20138.","journal-title":"Clin Chem"},{"key":"245_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ, et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7.","journal-title":"Gigascience"},{"key":"245_CR18","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2015","unstructured":"Core Team R. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2015."},{"key":"245_CR19","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1200\/JCO.2014.59.4671","volume":"33","author":"JJ Yang","year":"2015","unstructured":"Yang JJ, Landier W, Yang W, Liu C, Hageman L, Cheng, et al. Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia. J Clin Oncol. 2015;33:1235\u201342.","journal-title":"J Clin Oncol"},{"key":"245_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, et al. The Ensembl Variant Effect Predictor. Genome Biol. 2016;17:1\u201314.","journal-title":"Genome Biol"},{"key":"245_CR21","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1101\/gr.137323.112","volume":"22","author":"AP Boyle","year":"2012","unstructured":"Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012;22:1790\u20137.","journal-title":"Genome Res"},{"key":"245_CR22","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1093\/nar\/gkr917","volume":"40","author":"LD Ward","year":"2012","unstructured":"Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40:930\u20134.","journal-title":"Nucleic Acids Res"},{"key":"245_CR23","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale J, Thomas J, Salvatore M, Phillips R, Lo E, Shad S, et al. The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013;45:580\u20135.","journal-title":"Nat Genet"},{"key":"245_CR24","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2217\/pgs.13.38","volume":"14","author":"W Zabala","year":"2013","unstructured":"Zabala W, Cruz R, Barreiro-de Acosta M, Chaparro M, Panes J, Echarri A, et al. New genetic associations in thiopurine-related bone marrow toxicity among inflammatory bowel disease patients. Pharmacogenomics. 2013;14:631\u201340.","journal-title":"Pharmacogenomics"},{"key":"245_CR25","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/ng.2756","volume":"45","author":"HJ Westra","year":"2013","unstructured":"Westra H-J, Peters MJ, Esko T, Yaghootkar H, Schurmann C, Kettunen J, et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet. 2013;45:1238\u201343.","journal-title":"Nat Genet"},{"key":"245_CR26","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1371\/journal.pbio.1000001","volume":"6","author":"EL Heinzen","year":"2008","unstructured":"Heinzen EL, Ge D, Cronin KD, Maia JM, Shianna KV, Gabriel WN, et al. Tissue-specific genetic control of splicing: implications for the study of complex traits. PLoS Biol. 2008;6:2869\u201379.","journal-title":"PLoS Biol"},{"key":"245_CR27","doi-asserted-by":"crossref","first-page":"18759","DOI":"10.1016\/S0021-9258(18)37348-4","volume":"263","author":"J Spychala","year":"1988","unstructured":"Spychala J, Madrid-Marina V, Fox IH. High K(m) soluble 5\u2019-nucleotidase from human placenta. Properties and allosteric regulation by IMP and ATP. J Biol Chem. 1988;263:18759\u201365.","journal-title":"J Biol Chem"},{"key":"245_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cccn.2005.05.006","volume":"361","author":"C Brouwer","year":"2005","unstructured":"Brouwer C, Vogels-Mentink TM, Keizer-Garritsen JJ, Trijbels FJM, B\u00f6kkerink JPM, Hoogerbrugge PM, et al. Role of 5\u2032-nucleotidase in thiopurine metabolism: enzyme kinetic profile and association with thio-GMP levels in patients with acute lymphoblastic leukemia during 6-mercaptopurine treatment. Clin Chim Acta. 2005;361:95\u2013103.","journal-title":"Clin Chim Acta"},{"key":"245_CR29","doi-asserted-by":"publisher","first-page":"6185","DOI":"10.1074\/jbc.M007623200","volume":"276","author":"C Gazziola","year":"2001","unstructured":"Gazziola C, Ferraro P, Moras M, Reichard P, Bianchi V. Cytosolic high K(m) 5\u2032-nucleotidase and 5\u2032(3\u2032)-deoxyribonucleotidase in substrate cycles involved in nucleotide metabolism. J Biol Chem. 2001;276:6185\u201390.","journal-title":"J Biol Chem"},{"key":"245_CR30","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nm.3078","volume":"19","author":"G Tzoneva","year":"2013","unstructured":"Tzoneva G, Perez-Garcia A, Carpenter Z, Khiabanian H, Tosello V, Allegretta M, et al. Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL. Nat Med. 2013;19:368\u201371.","journal-title":"Nat Med"},{"key":"245_CR31","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/ng.2558","volume":"45","author":"JA Meyer","year":"2013","unstructured":"Meyer JA, Wang J, Hogan LE, Yang JJ, Dandekar S, Patel JP, et al. Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia. Nat Genet. 2013;45:290\u20134.","journal-title":"Nat Genet"},{"key":"245_CR32","first-page":"1699","volume":"90","author":"CM Galmarini","year":"2005","unstructured":"Galmarini CM, Cros E, Thomas X, Jordheim L, Dumontet C. The prognostic value of cN-II and cN-III enzymes in adult acute myeloid leukemia. Haematologica. 2005;90:1699\u2013701.","journal-title":"Haematologica"},{"key":"245_CR33","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2217\/pgs.12.102","volume":"13","author":"A Emadi","year":"2012","unstructured":"Emadi A, Karp JE. The clinically relevant pharmacogenomic changes in acute myelogenous leukemia. Pharmacogenomics. 2012;13:1257\u201369.","journal-title":"Pharmacogenomics"},{"key":"245_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1124\/jpet.111.182873","volume":"339","author":"AK Mitra","year":"2011","unstructured":"Mitra AK, Crews KR, Pounds S, Cao X, Feldberg T, Ghodke Y, et al. Genetic variants in cytosolic 5\u2019-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemia. J Pharmacol Exp Ther. 2011;339:9\u201323.","journal-title":"J Pharmacol Exp Ther"},{"key":"245_CR35","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1182\/blood-2012-10-464149","volume":"121","author":"ER Gamazon","year":"2013","unstructured":"Gamazon ER, Lamba JK, Pounds S, Stark AL, Wheeler HE, Cao X, et al. Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients. Blood. 2013;121:4366\u201376.","journal-title":"Blood"},{"key":"245_CR36","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1124\/dmd.108.023184","volume":"36","author":"LP Jordheim","year":"2008","unstructured":"Jordheim LP, Nguyen-Dumont T, Thomas X, Dumontet C, Tavtigian SV. Differential allelic expression in leukoblast from patients with acute myeloid leukemia suggests genetic regulation of CDA, DCK, NT5C2, NT5C3, and TP53. Drug Metab Dispos. 2008;36:2419\u201323.","journal-title":"Drug Metab Dispos"},{"key":"245_CR37","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nature25186","volume":"553","author":"G Tzoneva","year":"2018","unstructured":"Tzoneva G, Dieck CL, Oshima K, Ambesi-Impiombato A, S\u00e1nchez-Mart\u00edn M, Madubata CJ, et al. Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia. Nature. 2018;553:511\u20134.","journal-title":"Nature"},{"key":"245_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7604","volume":"6","author":"X Ma","year":"2015","unstructured":"Ma X, Edmonson M, Yergeau D, Muzny DM, Hampton OA, Rusch M, et al. Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia. Nat Commun. 2015;6:6604.","journal-title":"Nat Commun"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0245-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0245-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0245-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:35:43Z","timestamp":1684618543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-018-0245-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,10]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["245"],"URL":"https:\/\/doi.org\/10.1038\/s41375-018-0245-3","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,10]]},"assertion":[{"value":"29 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}